India, S. Korea, US, Japan, EU launch Biopharmaceutical Alliance

WhatsApp Group Join Now
Telegram Group Join Now

India, S. Korea, US, Japan, EU launch Biopharmaceutical Alliance

The Biopharmaceutical Alliance was created to address drug shortages that occurred during the Covid-19 pandemic.

South Korea, India, the United States, Japan, and the European Union (EU) have formed an alliance to strengthen the biopharmaceutical supply chain, the South Korean presidential office announced in Seoul on June 6.

South Korea’s Yonhap news agency reported that the first Biopharmaceutical Alliance meeting took place in San Diego during the Bio International Convention 2024. It included representatives from government officials and bio and pharmaceutical companies from participating countries.

  • The participants stressed the need for a reliable and sustainable supply chain and agreed to align their countries’ bio policies, regulations, and support for research and development.
  • They noted that the production of key raw materials and ingredients is concentrated in a few countries and decided to collaborate on creating a comprehensive pharmaceutical supply chain map.

The alliance was created because of shortages in drug supplies during the Covid-19 pandemic.

South Korea and the U.S. decided to form the alliance during their discussions on key emerging technologies in December. Later, they broadened it to include Japan, India, and the EU, according to the report.

WhatsApp Group Join Now
Telegram Group Join Now

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top